GERN Q2 2019 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$101,000-51.4% YoY

Gross Profit

-$10M-9933.7% margin

Operating Income

-$15M-15073.3% margin

Net Income

-$14M-14098.0% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+77.2%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$166M

Total Liabilities

$9M

Stockholders' Equity

$157M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$101,000	$208,000	-51.4%
Gross Profit	-$10M	-$2M	-348.7%
Operating Income	-$15M	-$7M	-110.2%
Net Income	-$14M	-$7M	-105.4%